Primary Appointment: Medicine- Hematology and Oncology
6/17/2025
Our tumor targeting strategy is based on arming activated T cells with low concentrations of bispecific antibodies to bridge the effector T cells with targets, resulting in tumor cell lysis,…
6/17/2025
Reduced intensity conditioning use, pre-transplant co-morbidity assessment.
6/17/2025
Dr. Williams was recognized in 2023 with the Master Clinician Award in the UVA School of Medicine. He is an Emeritus member of the Lymphoma Research Foundation’s Scientific Advisory Board…
